Orion Corp (ORNBV) – Strategy, SWOT and Corporate Finance Report

Orion Corp (ORNBV) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Orion Corp (Orion) develops, manufactures and markets human and veterinary pharmaceuticals, and active pharmaceutical ingredients (APIs). Its products include pharmaceuticals for the treatment of central nervous system disorders, cancer, and respiratory diseases. The company's pipeline encompasses investigational candidates for the treatment of amyotrophic lateral sclerosis, Parkinson’s disease, chronic obstructive pulmonary disease, and various cancer types. Orion’s client base consists of healthcare service providers and professionals, such as doctors, pharmacies, veterinarians, hospitals, healthcare centers, clinics and laboratories. The company sells its products in European markets through own sales network and in international markets through several partners and distributors. Orion is headquartered in Espoo, Finland.

Scope

• Detailed information on Orion Corp required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Orion Corp in the form of a SWOT analysis

• An in-depth view of the business model of Orion Corp including a breakdown and examination of key business segments

• News about Orion Corp, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Orion Corp and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Orion Corp as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Orion Corps business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Abbott Laboratories

Biohit Oyj

Biotie Therapies Ltd

F. Hoffmann-La Roche Ltd

GSK plc

Merck & Co Inc

Tasly Pharmaceuticals Inc

Abbott Laboratories

GSK plc

Tasly Pharmaceuticals Inc

Biohit Oyj

Merck & Co Inc

Biotie Therapies Ltd

F. Hoffmann-La Roche Ltd

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Orion Corp - Key Facts

Orion Corp - Key Employees

Orion Corp - Key Employee Biographies

Orion Corp - Major Products and Services

Orion Corp - History

Orion Corp - Company Statement

Orion Corp - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Orion Corp - Business Description

Product Category: Animal Health

Overview

Performance

Product Category: Fermion and Contract Manufacturing

Overview

Performance

Product Category: Other

Performance

Product Category: Proprietary Products

Overview

Performance

Product Category: Specialty Products

Overview

Performance

Geographical Segment: Finland

Performance

Geographical Segment: North America

Performance

Geographical Segment: Other Countries

Performance

Geographical Segment: Other Europe

Performance

Geographical Segment: Scandinavia

Performance

R&D Overview

Orion Corp - Corporate Strategy

Orion Corp - SWOT Analysis

SWOT Analysis - Overview

Orion Corp - Strengths

Orion Corp - Weaknesses

Orion Corp - Opportunities

Orion Corp - Threats

Orion Corp - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Orion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Orion Corp, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Orion Corp, Recent Deals Summary

Section 5 – Company’s Recent Developments

Apr 13, 2023: Orion publishes Interim Report for January–March 2023 on Thursday 27 April 2023

Mar 30, 2023: Orion is building a unique pharmaceutical research ecosystem in Finland – using data and artificial intelligence to shorten the development time of new innovative medicines

Feb 28, 2023: Orion Group Announces Financial Statement documents 2022, Corporate Governance Statement and Remuneration Report published

Feb 09, 2023: Orion Group Announces Financial Statement Release 2022

Feb 09, 2023: Notice to the Annual General Meeting of Orion Corporation

Jan 26, 2023: Orion publishes Financial Statement Release for 2022 on Thursday 9 February 2023

Jan 03, 2023: Alligator Bioscience and Orion expand immuno-oncology research alliance

Oct 20, 2022: Orion Group Interim Report January-September 2022

Oct 17, 2022: Changes in Orion Group Executive Management Board and new organisational structure as of 1 January 2023

Oct 06, 2022: Orion publishes Interim Report for January–September 2022 on Thursday 20 October 2022

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Orion Corp, Key Facts

Orion Corp, Key Employees

Orion Corp, Key Employee Biographies

Orion Corp, Major Products and Services

Orion Corp, History

Orion Corp, Subsidiaries

Orion Corp, Key Competitors

Orion Corp, Ratios based on current share price

Orion Corp, Annual Ratios

Orion Corp, Annual Ratios (Cont…1)

Orion Corp, Annual Ratios (Cont…2)

Orion Corp, Interim Ratios

Orion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Orion Corp, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Orion Corp, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Orion Corp, Performance Chart (2018 – 2022)

Orion Corp, Ratio Charts

Orion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Orion Corp, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports